Product Center

V-C-A-T Inhibitor (Martin and Lewis)



Cat. # Description Qty. Unit
212404 V-C-A-T Inhibitor (Martin and Lewis)
10 mL, antibiotic mixture of Vancomycin, Colistin, Anisomycin and Trimethoprim, lyophilized
10 SP

Intended Use:

V-C-A Inhibitor is an antibiotic mixture of vancomycin, colistin and anisomycin which is incorporated into culture media to permit the isolation of pathogenic Neisseria by inhibiting contaminating flora.

V-C-A-T Inhibitor is V-C-A Inhibitor plus trimethoprim to improve recovery of pathogenic Neisseria by increasing the selectivity of isolation media.


Catalog # Description Brand Quantity Unit
212404 V-C-A-T Inhibitor (Martin and Lewis)
10 mL, antibiotic mixture of Vancomycin, Colistin, Anisomycin and Trimethoprim, lyophilized
BBL 10 SP

BBL™ Medium Supplement for the Selection of Pathogenic Neisseria

V-C-A Inhibitor
V-C-A-T Inhibitor

Revision: 0399     Revision Date: 03/01/1999    

Intended Use:

V-C-A Inhibitor is an antibiotic mixture of vancomycin, colistin and anisomycin which is incorporated into culture media to permit the isolation of pathogenic Neisseria by inhibiting contaminating flora.

V-C-A-T Inhibitor is V-C-A Inhibitor plus trimethoprim to improve recovery of pathogenic Neisseria by increasing the selectivity of isolation media.



Product Summary:

V-C-A Inhibitor was developed as an improved inhibitory supplement relative to the V-C-N (Vancomycin-Colistin-Nystatin) Inhibitor employed in Thayer-Martin-type selective media for the isolation of Neisseria gonorrhoeae and N. meningitidis.1-4

It is employed in selective media, e.g., Martin-Lewis Agar,5 which is Chocolate Agar (BBL™ GC Agar Base or GC II Agar Base, Hemoglobin and IsoVitaleX™ Enrichment, a chemically defined supplement developed specifically to promote the growth of N. gonorrhoeae) supplemented with additional dextrose, V-C-A Inhibitor and trimethoprim lactate, to suppress the swarming of Proteus species.6 Because of its improved performance, it is particularly recommended for the isolation of pathogenic Neisseria.7

V-C-A-T Inhibitor may be used similarly as the V-C-A Inhibitor except that trimethoprim lactate has been included in the antibiotic mixture and the addition of the antibiotic separately is not required.



User Quality Control:

1. Examine lyophilized and restored supplement for signs of deterioration as noted under "Product Deterioration."

2. Check performance of the finished medium by inoculation with pure cultures of stable control organisms, producing known, desired reactions. The following cultures are recommended.

Martin-Lewis Agar
Neisseria gonorrhoeae
ATCC® 43069

Staphylococcus epidermidis
ATCC 12228

Candida albicans
ATCC 60193

Proteus mirabilis
ATCC 43071
Growth


Inhibition (partial)


Inhibition (partial)


Inhibition (partial)


Reagents:

Formulae:

V-C-A Inhibitor
  Approximate Formula Per 1 mL Restored Solution:
  Vancomycin  400   mcg
  Colistin  750   mcg
  Anisomycin  2.0   mg
 
V-C-A-T Inhibitor
  Approximate Formula Per 1 mL Restored Solution:
  Vancomycin  400   mcg
  Colistin  750   mcg
  Anisomycin  2.0   mg
  Trimethoprim Lactate  500   mcg
 


Warnings and Precautions:

For Laboratory Use

This Product Contains Dry Natural Rubber.

V-C-A Inhibitor and V-C-A-T Inhibitor are for use in culture media and not for use in human or animal therapy.

Observe aseptic techniques in the restoration and addition of these media supplements.

Read directions for use.



Information shown on this page is a short summary extracted from the Package Insert, available as a PDF under the Related Documents section of this page.